Chimeric and pegylated L-asparaginase: study of the conditions of expression, production and purification of an innovative anti-leukemic biopharmaceutical with low immunogenic potential
Más información
Fecha de publicación: | 2021 |
Objetivos: | 1) Optimize culture to produce a chimeric E. coli ASNase in bioreactor; 2) purify and N-terminal PEGylate this ASNase; 3) characterize structure and function; 4) evaluate in vitro cytotoxicity against leukaemic cell lines; and 5) evaluate in vivo in mouse models |
Año de Inicio/Término: | 2021-2023 |
Financiamiento/Sponsor: | UFRO-FAPESP |
Rol del Usuario: | COINVESTIGADOR(A) |
DOI: |
UFRO-FAPESP 2020/06982-3 |